Application of an optimized non-invasive prenatal testing for thalassemia based on change of haplotype doses
{{output}}
Patients affected by monogenic diseases impose a substantial burden on both themselves and their families. The primary preventive measure, i.e., invasive prenatal diagnosis, carries a risk of miscarriage and cannot be performed early in pregnancy. Hence, there... ...
